CompetitorsNarrow moat

Synektik (SNT) — moat facet

Synektik's most dangerous competitor is the company that supplies it, and the others are mostly fighting over growth.

Synektik has no competitor that does what it does, and four that could take parts of it. Each is a different kind of relationship, and only one of them is a company selling against it in the ordinary way.

Polish robotic-surgery market (zł m)83,12019123,12020235,12021310,42022624,12023 est.2 123,72028 fcstUpper Finance and Polish Federation of Hospitals, via Synektik annual report; 2023 estimate, 2028 forecast
A market forecast to more than triple in five years.

The most important is its own supplier. Intuitive can sell and service the da Vinci itself, and in March 2026 it did exactly that in Italy, Spain and Portugal, paying about $533,1 million for the distributors there1. Synektik's contract runs to 31 December 20312. A rival that is also your supplier does not need to win a tender against you; it needs only to decline to renew.

The second kind is rival robot makers. CMR Surgical's Versius arrived in Poland in 20213 and, with leasing and pay-per-procedure financing, placed five robots in the first half of 2022 while two new sites started with the da Vinci4. Medtronic's Hugo followed in December 2024 and reached four hospitals by October 20255. They compete with Intuitive's product and so with Synektik's catalogue, and Synektik cannot sell them.

The third is in radiopharmaceuticals, where Synektik makes rather than resells. Poland has nine cyclotrons; four were bought by public bodies and two more belong to other private producers6. Here the competition is local and ordinary: price, reliability and delivery range.

The fourth is the process. 85,5% of Synektik's revenue came from public tenders in the year to September 20257, and a tender's job is to make suppliers compete on price. For everything except the da Vinci, the rival is whichever distributor of another manufacturer bids lower.

The market is growing fast enough that none of these has yet cost Synektik much. An industry report cited by the company estimates the Polish robotic-surgery market at 624,1 million złoty in 2023, up 101%, and forecasts more than 2,1 billion złoty by 20288. In a market expanding at that pace, competitors mostly take growth rather than customers.

Rival robots also benefit from the same public money as Synektik. The Hugo at the National Institute of Oncology in Kraków, installed in August 2025, cost more than 17 million złoty and was financed from European Union funds, and the one in Łomża, more than 10 million złoty, from the National Recovery Plan9; Synektik's own oncology equipment tenders in the half-year to March 2026 were financed from the same source10. The competition is often over which manufacturer a hospital spends a government grant on.

The verdict is narrow. Against rival robots and other distributors the da Vinci and its installed base hold; against the supplier, Synektik's position lasts exactly as long as its contract. Follow the forecast market itself: if the Polish market reaches the forecast and the da Vinci's share of it slips, the rivals are taking the growth.

Moat trajectory: Holding steady

Rival robots are few; the supplier took other territories direct.

The number that tests this moat
Reported
Polish robotic-surgery market, industry estimate
624,1m zł in 2023 (+101%), forecast above 2,1bn zł in 2028

The market Synektik and its rivals share; includes procedures, robots, instruments and service.

Source: Synektik annual management board report, year to September 2025 ↗
Dig deeper
DIG DEEPER 01
Intuitive: The Supplier That Could Go Direct
Intuitive can replace Synektik without winning a single tender, simply by not renewing.
DIG DEEPER 02
Hugo and Versius: The Robots Sold Around Synektik
Rival robots broke into Poland on financing terms, and the da Vinci still works in more than 70 hospitals to their handful.
DIG DEEPER 03
The Other Cyclotrons
Synektik's tracer rivals are two private producers and four public plants, and the fight is over the basic product.
DIG DEEPER 04
Whoever Bids Lowest
For everything except the da Vinci, Synektik's rival is whoever bids lowest in the next tender.
References
  1. ReportedIntuitive can sell and service the da Vinci itself, and in March 2026 it did exactly that in Italy, Spain and Portugal, paying about $533,1 million for the distributors there.
    Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
  2. ReportedSynektik's contract runs to 31 December 2031.
    Synektik interim financial statements for 1 October - 31 December 2025 - including the annex extending the da Vinci distribution agreement to 31 December 2031 and adding Ukraine, and the 10,75 złoty dividend. — October - December 2025 · publ. February 2026 · source ↗
  3. ReportedCMR Surgical's Versius arrived in Poland in 2021 and, with leasing and pay-per-procedure financing, placed five robots in the first half of 2022 while two new sites started with the da Vinci.
    Alert Medyczny - CMR Surgical Versius in Poland: the first contract signed by Salve Medica in Łódź on 23 August 2021; da Vinci in more than 70 hospitals. — 2025 · publ. 2025 · source ↗
  4. ReportedCMR Surgical's Versius arrived in Poland in 2021 and, with leasing and pay-per-procedure financing, placed five robots in the first half of 2022 while two new sites started with the da Vinci.
    Rynek Zdrowia - report on robotic surgery in Poland in the first half of 2022: five Versius robots against two new da Vinci sites, leasing and pay-per-procedure removing a minimum 10 million złoty outlay, the robotic prostatectomy tariff twice the laparoscopic one, 17 hospitals in three months. — First half of 2022 · publ. 2022 · source ↗
  5. ReportedMedtronic's Hugo followed in December 2024 and reached four hospitals by October 2025.
    Alert Medyczny - Medtronic Hugo RAS in Poland: first clinical use on 9 December 2024 in Jastrzębie-Zdrój, installed in four hospitals by October 2025. — October 2025 · publ. 2025 · source ↗
  6. ReportedPoland has nine cyclotrons; four were bought by public bodies and two more belong to other private producers.
    Synektik annual management board report for the fiscal year to 30 September 2025 - description of the markets: robotic surgery in Poland, PET scanners, cyclotrons and NFZ-funded PET studies. — October 2024 - September 2025 · publ. December 2025 · source ↗
  7. Reported85,5% of Synektik's revenue came from public tenders in the year to September 2025, and a tender's job is to make suppliers compete on price.
    Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗
  8. ReportedAn industry report cited by the company estimates the Polish robotic-surgery market at 624,1 million złoty in 2023, up 101%, and forecasts more than 2,1 billion złoty by 2028.
    Synektik annual management board report for the fiscal year to 30 September 2025 - description of the markets: robotic surgery in Poland, PET scanners, cyclotrons and NFZ-funded PET studies. — October 2024 - September 2025 · publ. December 2025 · source ↗
  9. ReportedThe Hugo at the National Institute of Oncology in Kraków, installed in August 2025, cost more than 17 million złoty and was financed from European Union funds, and the one in Łomża, more than 10 million złoty, from the National Recovery Plan; Synektik's own oncology equipment tenders in the half-year to March 2026 were financed from the same source.
    Alert Medyczny - Medtronic Hugo RAS in Poland: first clinical use on 9 December 2024 in Jastrzębie-Zdrój, installed in four hospitals by October 2025. — October 2025 · publ. 2025 · source ↗
  10. ReportedThe Hugo at the National Institute of Oncology in Kraków, installed in August 2025, cost more than 17 million złoty and was financed from European Union funds, and the one in Łomża, more than 10 million złoty, from the National Recovery Plan; Synektik's own oncology equipment tenders in the half-year to March 2026 were financed from the same source.
    Synektik management board report for the half-year 1 October 2025 - 31 March 2026 - including the HistoSonics Edison exclusive distribution agreement and the installed base at March 2026. — October 2025 - March 2026 · publ. June 2026 · source ↗
Sources
Generated September 24, 2026